Vanguard Global Advisers’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.02K Hold
14,944
– – ﹤0.01% 3612
2026
Q2
$4.06K Hold
14,944
– – ﹤0.01% 3571
2026
Q1
$3.93K Buy
+14,944
New +$4.15K ﹤0.01% 3576

Other funds holding IGC

Vanguard Global Advisers's IGC Position: Q3 2026 in Review

Vanguard Global Advisers held its IGC Pharma (IGC) position steady in Q3 2026 at 14,944 shares worth $4.02K. The position accounts for ﹤0.01% of the portfolio, ranked #3612.

Vanguard Global Advisers first reported a position in IGC in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.06K in Q2 2026. 29 funds tracked by Wall St. Rank hold IGC as of Q3 2026.

  • Vanguard Global Advisers held 14,944 shares of IGC Pharma worth $4.02K as of Q3 2026.
  • Vanguard Global Advisers left its IGC Pharma share count unchanged in Q3 2026.
  • IGC Pharma made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3612 holding.
  • Vanguard Global Advisers first reported a position in IGC Pharma in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's IGC Pharma position peaked at $4.06K in Q2 2026.
  • 29 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.